Bladder Hyperactivity Induced by Oxidative Stress and Bladder Ischemia: A Review of Treatment Strategies with Antioxidants

Int J Mol Sci. 2021 Jun 2;22(11):6014. doi: 10.3390/ijms22116014.

Abstract

Overactive bladder (OAB) syndrome, including frequency, urgency, nocturia and urgency incontinence, has a significantly negative impact on the quality-of-life scale (QoL) and can cause sufferer withdrawal from social activities. The occurrence of OAB can result from an imbalance between the production of pro-oxidants, such as free radicals and reactive species, and their elimination through protective mechanisms of antioxidant-induced oxidative stress. Several animal models, such as bladder ischemia/reperfusion (I/R), partial bladder outlet obstruction (PBOO) and ovarian hormone deficiency (OHD), have suggested that cyclic I/R during the micturition cycle induces oxidative stress, leading to bladder denervation, bladder afferent pathway sensitization and overexpression of bladder-damaging molecules, and finally resulting in bladder hyperactivity. Based on the results of previous animal experiments, the present review specifically focuses on four issues: (1) oxidative stress and antioxidant defense system; (2) oxidative stress in OAB and biomarkers of OAB; (3) OAB animal model; (4) potential nature/plant antioxidant treatment strategies for urinary dysfunction with OAB. Moreover, we organized the relationships between urinary dysfunction and oxidative stress biomarkers in urine, blood and bladder tissue. Reviewed information also revealed the summary of research findings for the effects of various antioxidants for treatment strategies for OAB.

Keywords: antioxidants; bladder dysfunction; overactive bladder; oxidative stress.

Publication types

  • Review

MeSH terms

  • Antioxidants / therapeutic use*
  • Humans
  • Ischemia / drug therapy*
  • Ischemia / pathology
  • Oxidative Stress / genetics
  • Oxidative Stress / physiology
  • Urinary Bladder / drug effects
  • Urinary Bladder / pathology
  • Urinary Bladder, Overactive / drug therapy*
  • Urinary Incontinence / drug therapy*
  • Urinary Incontinence / pathology

Substances

  • Antioxidants